| WKN: | 886455 |
| ISIN: | GB0009895292 |
| Land: | Großbritannien |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Pharma |
Weshalb die Astrazeneca-Aktie
ein A-Rating hat,
erfahren Sie im Performance-Check
vom 28. November 2025 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2005 | 26,70 | 41,30 | 54,68% |
| 2 | 2019 | 65,19 | 90,56 | 38,92% |
| 3 | 2000 | 39,99 | 54,50 | 36,28% |
| 4 | 2014 | 43,22 | 58,41 | 35,15% |
| 5 | 2025 | 127,00 | 161,00 | 26,77% |
| 6 | 2021 | 83,05 | 103,66 | 24,82% |
| 7 | 2022 | 103,66 | 127,50 | 23,00% |
| 8 | 2013 | 36,08 | 43,22 | 19,79% |
| 9 | 1998 | 30,42 | 35,91 | 18,05% |
| 10 | 2003 | 33,40 | 38,80 | 16,17% |
| 11 | 2009 | 28,59 | 32,49 | 13,64% |
| 12 | 2018 | 57,83 | 65,19 | 12,73% |
| 13 | 1999 | 35,91 | 39,99 | 11,36% |
| 14 | 2017 | 52,94 | 57,83 | 9,24% |
| 15 | 2010 | 32,49 | 35,10 | 8,03% |
| 16 | 2015 | 58,41 | 62,95 | 7,77% |
| 17 | 2024 | 121,85 | 127,00 | 4,23% |
| 18 | 2012 | 35,30 | 36,08 | 2,21% |
| 19 | 2011 | 35,10 | 35,30 | 0,57% |
| 20 | 2006 | 41,30 | 40,92 | -0,92% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2002 | 51,00 | 33,40 | -34,51% |
| 2 | 2004 | 38,80 | 26,70 | -31,19% |
| 3 | 2007 | 40,92 | 29,79 | -27,20% |
| 4 | 2016 | 62,95 | 52,94 | -15,90% |
| 5 | 2020 | 90,56 | 83,05 | -8,29% |
| 6 | 2001 | 54,50 | 51,00 | -6,42% |
| 7 | 2023 | 127,50 | 121,85 | -4,43% |
| 8 | 2008 | 29,79 | 28,59 | -4,03% |
| 9 | 2006 | 41,30 | 40,92 | -0,92% |
| 10 | 2011 | 35,10 | 35,30 | 0,57% |
| 11 | 2012 | 35,30 | 36,08 | 2,21% |
| 12 | 2024 | 121,85 | 127,00 | 4,23% |
| 13 | 2015 | 58,41 | 62,95 | 7,77% |
| 14 | 2010 | 32,49 | 35,10 | 8,03% |
| 15 | 2017 | 52,94 | 57,83 | 9,24% |
| 16 | 1999 | 35,91 | 39,99 | 11,36% |
| 17 | 2018 | 57,83 | 65,19 | 12,73% |
| 18 | 2009 | 28,59 | 32,49 | 13,64% |
| 19 | 2003 | 33,40 | 38,80 | 16,17% |
| 20 | 1998 | 30,42 | 35,91 | 18,05% |